Pharmaceutical

U.S. demand for pharmaceutical packaging products is expected to increase slightly in the next few years as drug makers upgrade the barrier, security and functional properties of their packaging systems.

London-based multinational company Hikma Pharmaceuticals PLC has reached an asset acquisition agreement with Ben Venue Laboratories for the purchase of its U.S. generic injectables division, Bedford Laboratories, for $300 million.